Trials / Completed
CompletedNCT06447259
Drug Burden Index is Associated With Malnutrition in Community-dwelling Dementia Patients
A Rising Drug Burden Index, Not Anticholinergic Burden, is Related With Malnutrition in Community-dwelling Older Adults With Dementia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 415 (actual)
- Sponsor
- Sultan Keskin Demircan · Other Government
- Sex
- All
- Age
- 65 Years – 100 Years
- Healthy volunteers
- —
Summary
Malnutrition leads to poor clinical outcomes in dementia patients. The investigator aimed to examine the association between drug burden index (DBI) and anticholinergic burden (ACB) scores with nutrition status in community-dwelling older adults with dementia, considering that drugs may contribute malnutrition. A total of 415 outpatients with dementia, evaluated by Mini Nutrition Assessment test and registered drug information, are included in the study. The investigator calculated the DBI as the sum of all sedatives and anticholinergics taken continuously for at least four weeks prior to admission and evaluated the ACB score. Practice Impact: Due to accompanying chronic diseases and symptoms, cholinergic and/or sedative-loaded drugs are often prescribed to dementia patients. In this study, İnvestigators emphasized that in addition to the cholinergic loads of the drugs used, their sedative loads and the drug doses they use are also important. Avoiding prescribing these medications to patients with dementia will protect them from malnutrition and its negative consequences.
Conditions
Timeline
- Start date
- 2023-05-20
- Primary completion
- 2023-10-01
- Completion
- 2023-12-10
- First posted
- 2024-06-07
- Last updated
- 2024-06-07
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT06447259. Inclusion in this directory is not an endorsement.